PR Newswire BiotechOriginal article
NEW YORK BLOOD CENTER ENTERPRISES APPOINTS MEGHAN DELANEY, DO, MPH, AS NEXT PRESIDENT & CHIEF EXECUTIVE OFFICER
Neutral
AI Analysis
Summary
New York Blood Center Enterprises appointed Meghan Delaney, DO, MPH, as President and CEO, replacing outgoing CEO Christopher D. Hillyer, MD, who will transition to Special Advisor to the Board.
Importance:2/10
Sentiment:
0.00
management_changeleadership_appointmentexecutive_transition
Read the original article
Published by PR Newswire Biotech on October 12, 2026 8:47 PM
